Ardent Health Partners’ (ARDT) “Overweight” Rating Reiterated at Stephens

Stephens reiterated their overweight rating on shares of Ardent Health Partners (NYSE:ARDT) in a research note issued to investors on Wednesday morning,Benzinga reports. They currently have a $22.00 target price on the stock.

Other analysts have also issued reports about the company. Morgan Stanley dropped their price objective on Ardent Health Partners from $23.50 to $22.00 and set an “overweight” rating on the stock in a report on Tuesday, January 21st. Truist Financial dropped their price target on shares of Ardent Health Partners from $22.00 to $21.00 and set a “buy” rating on the stock in a research note on Monday, January 6th. Royal Bank of Canada reduced their price objective on shares of Ardent Health Partners from $23.00 to $21.00 and set an “outperform” rating for the company in a research report on Tuesday, March 4th. Finally, JPMorgan Chase & Co. reiterated a “neutral” rating and issued a $20.00 target price on shares of Ardent Health Partners in a research report on Tuesday, December 17th. Two investment analysts have rated the stock with a hold rating, eight have issued a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat, Ardent Health Partners currently has a consensus rating of “Buy” and a consensus price target of $21.18.

Ardent Health Partners Price Performance

Shares of NYSE ARDT opened at $13.18 on Wednesday. The company has a debt-to-equity ratio of 0.78, a current ratio of 1.91 and a quick ratio of 1.78. The company’s fifty day moving average price is $14.41 and its 200 day moving average price is $16.25. Ardent Health Partners has a 1 year low of $12.87 and a 1 year high of $20.72.

Ardent Health Partners (NYSE:ARDT) last posted its earnings results on Wednesday, February 26th. The company reported $0.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.50 by $0.31. The firm had revenue of $1.61 billion for the quarter, compared to analysts’ expectations of $1.48 billion. Equities analysts forecast that Ardent Health Partners will post 1.23 earnings per share for the current fiscal year.

Institutional Trading of Ardent Health Partners

Hedge funds have recently bought and sold shares of the business. Ventas Inc. acquired a new position in shares of Ardent Health Partners during the 4th quarter worth approximately $159,570,000. Wellington Management Group LLP purchased a new position in Ardent Health Partners during the third quarter worth approximately $28,724,000. Point72 Asset Management L.P. acquired a new position in Ardent Health Partners during the third quarter worth $27,428,000. Goldentree Asset Management LP purchased a new stake in Ardent Health Partners in the 3rd quarter valued at $22,897,000. Finally, Franklin Resources Inc. purchased a new stake in Ardent Health Partners in the 3rd quarter valued at $15,839,000.

About Ardent Health Partners

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.